219: AMR: what is it, why should investors care?

In this special episode of LGIM talks, Dame Sally Davies, UK Special Envoy on antimicrobial resistance, talks to Michael Marks about the dangers of AMR and how an unwillingness to address this health issue affects not just patients but the whole of the food chain, our water system and ultimately investors. This episode was recorded as part of LGIM’s Sustainability Summit and is hosted by Michael Marks, Head of Responsible Investment Integration.